Investor profile
CR-CP Life Science Fund has backed 2 European tech companies across 3 funding rounds between 2020 and 2022, joining rounds totalling €96M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Novadip Biosciences | Belgium | 2 | €59M |
| ReViral | UK | 1 | €37M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Novadip Biosciences | Series B | €40M | 2022-11 |
| ReViral | Series C | €37M | 2020-08 |
| Novadip Biosciences | Series B | €19M | 2021-11 |
